Etiology and Pathophysiology of Cheyne‑Stokes Respiration

Primary Causes (as classified by the International Classification of Sleep Disorders, 3rd edition, text revision)

Heart failure is the predominant cause of Cheyne‑Stokes respiration, accounting for the majority of adult cases with systolic dysfunction. The disorder is also observed, though less well defined, in pediatric populations with moderate‑to‑severe cardiac impairment. [1][2]
Cerebrovascular events (stroke) and other neurological disorders constitute a major etiologic group; Cheyne‑Stokes patterns often signal severe central nervous system injury. [1][2]
Renal failure and metabolic disturbances can precipitate Cheyne‑Stokes breathing by altering systemic acid‑base balance and enhancing chemoreceptor sensitivity. 1
Exposure to high altitude induces hyperventilation‑related hypocapnia during sleep, which may trigger the cyclic breathing pattern. [4][5]
Opioid analgesics provoke central sleep apnea through depression of the central respiratory drive and reduced chemosensitivity, a mechanism distinct from the heightened chemosensitivity seen in cardiac‑related cases. [3][2]4
Primary (idiopathic) central sleep apnea with a Cheyne‑Stokes pattern occurs in the absence of identifiable cardiac, neurological, or medication‑related contributors. [1][2]

The final common pathway involves post‑hyperventilation hypocapnia that lowers arterial CO₂ below the apneic threshold, thereby inducing central apneas. This occurs when inhibitory influences on respiratory stability outweigh excitatory drives. [3][2]
During non‑REM sleep, the wakefulness “drive to breathe” is withdrawn, making ventilation entirely dependent on arterial CO₂ levels and unmasking the hypocapnic apneic threshold. [2][4]

Increased controller gain – heightened chemoreceptor sensitivity to CO₂ and O₂ produces exaggerated ventilatory responses that overshoot the set point, sustaining the oscillatory breathing pattern. [3][2]
Circulatory delay – prolonged transit time between the lungs and central chemoreceptors (as seen in low‑output heart failure) creates a phase lag that destabilizes the respiratory control loop. (Supported by the same mechanistic citations above.)
Sleep‑state dependency – non‑REM sleep eliminates behavioral and wakefulness drives, leaving chemical control as the sole regulator of breathing and exposing the system to instability. [2][4]

Central sleep apnea with Cheyne‑Stokes respiration carries a substantial mortality risk; approximately 20 % of affected individuals die within five years, based on large health‑system cohort data. [3][1]

Accurate differentiation from obstructive sleep apnea requires esophageal pressure monitoring, as hypopnea‑dominant patterns can be misclassified without this technique. [1][2]